SOLICITATION NOTICE
A -- Prospective Cohort to Evaluate the Immunogenicity and Effectiveness of COVID-19 Vaccines among Previously Infected and Uninfected Essential and Frontline Workers in a US State or Region
- Notice Date
- 3/21/2022 5:44:15 AM
- Notice Type
- Presolicitation
- NAICS
- 611310
— Colleges, Universities, and Professional Schools
- Contracting Office
- CDC OFFICE OF ACQUISITION SERVICES ATLANTA GA 30333 USA
- ZIP Code
- 30333
- Solicitation Number
- 64444
- Response Due
- 4/6/2022 8:00:00 AM
- Point of Contact
- Mark Draluck, Phone: 7704880938, Pellumbeshe Hoxhaj
- E-Mail Address
-
syq1@cdc.gov, kfx2@cdc.gov
(syq1@cdc.gov, kfx2@cdc.gov)
- Description
- The Centers for Disease Control and Prevention intends to award, on a sole source basis, a cost reimbursable contract to the University of Arizona, 888 N Euclid Ave RM 510, Tucson, AZ 85719, for an evaluation of the field performance of COVID-19 vaccines, including immunogenicity and effectiveness among essential and frontline workers with and without prior SARs-CoV-2 infections.� The University of Arizona initiated the Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance Study (AZ HEROES) prospective cohort in August 2020 and since then has enrolled and maintained a cohort of over 3,000 participants.� No other existing cohort includes the number and composition of participants (many of whom are high-risk for COVID-19), with rigorous follow-up and extensive laboratory and clinical data collection required for these evaluations.� Continuing the existing cohort will allow CDC to efficiently and expediently assess the effect of booster does and VE against new and future variants.� Additionally, CDC requires that vaccine evaluations be implemented consistent with study design features and methodologies of other CDC funded COVID-19 cohorts.� AZ HEROES has an ongoing collaboration and coordination with the Research on the Epidemiology of SARs-CoV-2 in Essential Response Personnel (RECOVER) cohorts in 6 US cities.� This collaboration and their use of common surveillance and laboratory methods ensures that CDC is able to compare and combine results across cohorts in a valid, reliable, and timely manner, increasing the sample size to allow for more precise findings improve generalizability of finds by capturing more diverse populations.� The anticipated period of performance is from 15 June 2022 through 14 June 2023.� This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1 and 41 U.S.C. 3304(a)(1).� Interested persons may identify their interest and capability to respond to the requirement or submit proposals.� This notice of intent is not a request for competitive offers; however, all offers/responses received within 15 days of the issuance of this notice will be considered by the Government.� A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.� Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.� All offers/responses should be emailed to Mark Draluck at syq1@cdc.gov by 11:00 A.M. Eastern Time, 6 April 2022.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/1eeaa1933a5443b78b8b3b6c75bf69e7/view)
- Place of Performance
- Address: Tucson, AZ 85719-4824, USA
- Zip Code: 85719-4824
- Country: USA
- Zip Code: 85719-4824
- Record
- SN06273392-F 20220323/220321230058 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |